NCT01521507View on ClinicalTrials.gov

Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2014

Conditions
Meibomian Gland DysfunctionDry Eye
Interventions
DEVICE

LipiFlow System

In-office device treatment for meibomian gland dysfunction by a physician

DEVICE

Warm Compress Therapy + Lid Scrub

At-home daily warm compress therapy and lid hygiene

Trial Locations (9)

33176

Center for Excellence in Eye Care, Miami

41017

Cincinnati Eye Institute - Northern Kentucky, Edgewood

50046

Jackson Eye, Lake Villa

55082

Associated Eye Care, Stillwater

60169

Chicago Cornea Consultants, Ltd., Hoffman Estates

63131

Ophthalmology Consultants, Ltd., St Louis

72703

McDonald Eye Associates, Fayetteville

92653

Harvard Eye Associates, Laguna Hills

01890

Charles River Eye Associates, Winchester

All Listed Sponsors
lead

TearScience, Inc.

INDUSTRY

NCT01521507 - Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye | Biotech Hunter | Biotech Hunter